Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lorvick

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Lancet (London, England)|June 23, 1998
Harm reduction and needle exchange programmesR N Bluthenthal, A H Kral, J Lorvick, et al.
Lancet (London, England)|May 18, 2001
Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysisA H Kral, R N Bluthenthal, J Lorvick, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|December 28, 1999
Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk communityJ Lorvick, S Thompson, B R Edlin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 6, 2001
Trends in HIV seroprevalence and risk among gay and bisexual men who inject drugs in San Francisco, 1988 to 2000R N Bluthenthal, A H Kral, L Gee, et al.
The New England Journal of Medicine|July 21, 2001
Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?B R Edlin, K H Seal, J Lorvick, et al.
American Journal of Public Health|October 31, 2001
Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998-1999K H Seal, A H Kral, L Gee, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 1, 1997
Two-step tuberculin skin testing of injection drug users recruited from community-based settingsA R Lifson, S M Grant, J Lorvick, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Lancet (London, England)|June 23, 1998
Harm reduction and needle exchange programmesR N Bluthenthal, A H Kral, J Lorvick, et al.
Lancet (London, England)|May 18, 2001
Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysisA H Kral, R N Bluthenthal, J Lorvick, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|December 28, 1999
Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk communityJ Lorvick, S Thompson, B R Edlin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 6, 2001
Trends in HIV seroprevalence and risk among gay and bisexual men who inject drugs in San Francisco, 1988 to 2000R N Bluthenthal, A H Kral, L Gee, et al.
The New England Journal of Medicine|July 21, 2001
Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?B R Edlin, K H Seal, J Lorvick, et al.
American Journal of Public Health|October 31, 2001
Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998-1999K H Seal, A H Kral, L Gee, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 1, 1997
Two-step tuberculin skin testing of injection drug users recruited from community-based settingsA R Lifson, S M Grant, J Lorvick, et al.
Pageof 2